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Telehomecare is fast becoming a viable solution to the problems faced by many community 
care agencies as the population ages and we consider how we can assist people living with 
chronic illness to manage their disease more effectively to improve their quality of life and 
reduce the demand on health services. One of the growing areas of telehomecare is the 
remote monitoring of patients’ vital signs by a clinician using equipment installed in the 
patient’s own home. Remote monitoring has gained momentum in recent years because it is 
seen not only as a way of providing prompt medical intervention before deterioration in the 
patient’s condition which can prevent unnecessary hospital admissions,1 but also as a way of 
managing staffing shortages, reducing costs,2 and improving patients’ knowledge and self-
efficacy.3 
 
One particular chronic condition that requires ongoing self-management to minimise 
morbidity and has begun to show positive outcomes using remote monitoring, is Chronic 
Obstructive Pulmonary Disease (COPD).4 COPD is a progressive and disabling disease 
which causes restrictions in lung airflow. People with COPD can often suffer from acute 
exacerbations which are characterised by severe shortness of breath, coughing fits and 
sputum production.4 These exacerbations are not only costly in terms of increased 
healthcare utilisation and hospitalisations, but they can also significantly reduce the quality of 
life for the person living with COPD.5 
 
While there is a growing body of research on the benefits of telehomecare for chronic 
conditions such as heart failure6, diabetes7 and wounds8, there is still limited 
methodologically sound evidence in relation to the benefits and financial viability of 
telehealth monitoring for people with COPD.1 A recent systematic review of the literature 
available on home telemonitoring for pulmonary conditions found only two studies which 
conducted a detailed cost analysis of this approach.9 They concluded that more evaluative 
research, utilising larger samples sizes and more robust study designs, particularly 
randomised controlled trials, were required in order to confirm the economic viability of this 
kind of telehomecare program.9  Another review by Polisena and colleagues also reported 
that although home telehealth was generally clinically effective, the current evidence 
regarding the effect on health service utilisation was limited and that once again more robust 




This study therefore aimed to address this gap in current knowledge on health service 
utilisation, cost effectiveness and any associated benefits of telehealth monitoring for people 




Study Design & Population 
 
A randomised controlled trial was used to compare the outcomes for participants receiving 
the telehealth monitoring with participants receiving information only.  
 
The study was conducted by Silver Chain, a large health and community care organisation 
based in Western Australia. The study population consisted of Silver Chain clients who: had 
a diagnosis of COPD, were receiving domiciliary oxygen, spoke English and lived in the 
metropolitan area.  Clients were excluded if they had dementia, were receiving palliative 
care, did not have a telephone landline or were unable to use the telehealth equipment due 
to cognitive or physical impairment. Ethics approval for this project was granted by the Silver 




Earlier analysis of Silver Chain client hospital admission data had found an annual 
admission rate of 1.7 times for clients with COPD.  Previous research examining the impact 
of telehealth monitoring on individuals with chronic disease has found a reduction in hospital 
admissions of up to 68% can be achieved.11 Anticipating a 45% reduction in hospital 
admissions it was calculated that 40 participants in each group were required in order to 




Clients meeting the selection criteria were identified using Silver Chain’s client information 
management system (ComCare) and were then invited to participate by letter. The letter 
included an information statement and explained that a research assistant would telephone 
them in the next few days to discuss the research trial. If during this phone call clients 
expressed an interest in participating, a time was arranged to visit them at home. During this 
visit the research assistant obtained informed consent (which included permission to contact 
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their GP/specialist), collected baseline data and randomly assigned the participant to the 
intervention or control group.  
 
Prior to recruitment, the random number generator in STATA version 9 was used to 
randomly allocate 80 study numbers to the intervention or control group (40 in each).   
Envelopes were then made up with the study number written on the outside and the group 
assignment inside.   
 
After a participant had been recruited, their GP/specialist was sent a fax which included an 
information statement and a consent form.  The fax explained that their patient had 
consented to take part and requested that they accept clinical governance for the participant 
during the research.  If their patient was allocated to the telehealth group, the fax also 
included a threshold document for the doctor to define the normal parameters for their 





This study used the Docobo HealthHub, a small portable unit that has an integrated display 
and large functional keys. Participants were visited at home by the telehealth nurse who 
installed the telehealth equipment and trained participant’s in its use.  Participants were also 
provided with an educational book about COPD and a telehealth instruction manual.  
 
Participants measured their vital signs (blood pressure, weight, temperature, pulse, oxygen 
saturation levels) and answered questions relating to their general state of health, on a daily 
basis.  These were transmitted automatically via telephone to a secure web site where they 
were monitored daily by the telehealth nurse. Any deviations outside the participant’s normal 
parameters, specified by their GP or specialist, triggered an alert.  The telehealth nurse 
would then phone the participant to discuss their measurements and provide advice/support 
or recommend they make an appointment to visit their GP. The outcome of the phone call 
and any recommendations/actions taken were then recorded on the telehealth website. The 
participants’ GPs/specialists were also provided with a secure log-in so they could access 
the telehealth website and view their patient’s readings.  
 
The control group were also visited by the telehealth nurse who provided them with the 






Participants were provided with a calendar to record every time they used any health 
service. This information was then collected by phone each month, for the six month study 
period.  Participant demographics and the number and duration of telehealth nurse visits, 
telephone calls and monitoring, were extracted from ComCare. Quality of life was measured 
during the initial interview and again at six months using the Chronic Respiratory 
Questionnaire Self-Administered Standardized Version (CRQ-SAS).12 Client satisfaction was 




Paired and Independent samples T-tests and Chi-square tests were used to compare the 
demographics, quality of life and health service use of the two groups. Stata version 11 was 
used for all analyses. 
 
The cost evaluation examined the extra costs of providing the telehealth intervention and 
determined whether there was a net benefit in health system usage and any annualised cost 
savings for those in the telehealth group compared to the control group. Two types of costs 
were included: actual equipment costs and labour costs which included telehealth nurse 
visits, daily monitoring calls and any associated travel expenses to participants’ homes, 
calculated as a weekly cost. Net benefits were derived by comparing the health system 
usage of both groups. Unit costs for GP, Specialist and Emergency Department (ED) visits 
were taken from the 2005/06 unit costs in Table 7.2 of Flatau et al (2008) adjusted by 6.51% 
per annum increase in ABS health services price index.14 Hospital visit costs were based on 
length of stay rather than number of hospitalisations.  Length of stay cost was calculated 
using the average cost per bed-day in public hospitals15 adjusted by a 6.51% per annum 




Eighty clients (40 telehealth and 40 control) were recruited into the study, with seventy one 
clients (36 telehealth and 35 control) completing the trial.  Nine participants were lost to 
follow-up (7 deceased, 2 withdrawn). Of the two participants who withdrew, one was unable 






Table 1 shows the gender, age, living arrangement and carer availability for both groups, 
none of these were statistically significant. 
 
Health Service Usage 
 
Table 2 shows the number of GP and specialist visits, ED presentations, number of hospital 
admissions and length of stay in hospital for each group. These health contacts are shown 
for COPD related contacts, non-COPD related contacts and the combined totals.   
 
There are substantial differences between the two groups in their health service usage. The 
telehealth group were hospitalised less than half as many times as the control group and 
spent a total of 77 fewer days in hospital over the six month period. The telehealth group had 
nearly 25% more GP visits than the control group, but the majority of these visits were non 
COPD related. None of these differences reached statistical significance. 
 
Annual Cost Savings 
 
Costs and net benefits of the telehealth group compared to the control group were calculated 
for the six month period and then annualised. Two types of costs were included, equipment 
costs and labour costs.  Equipment costs are shown in Table 3.  They include the cost of the 
equipment depreciated over three years using the straight line method plus the weekly cost 
of monitoring.  Table 4 applies unit costs to the difference in all health system contacts. 
 
As can be seen in Table 5 the annualised net savings in the telehealth group were $2,931 
per person.  
 
Quality Of Life 
 
The questions in the CRQ-SAS are divided into four domains; dyspnoea, fatigue, emotional 
function and mastery (ability in self-managing their disease) and each are scored separately.  
There were no statistically significant differences between the telehealth and control group 
for any of the domains at baseline or at six months.  There was however, a clinically 
significant change found within the telehealth group for the mastery domain between 
baseline and six months. The minimum amount of change that has been found to be 
clinically significant or important in a respondents day to day life, is an improvement of 0.5 
per question per dimension.16 There are four questions in mastery domain and therefore to 
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achieve clinical significance a change of 2 is required. The Telehealth group improved by 2.3 




Overall, participants found the equipment easy to use and entering their daily measurements 
took an average of five minutes.  Approximately half felt that the telehealth intervention had 
reduced the number of times they had been to hospital.  Participants commented that in the 
past they may have gone to hospital because they were worried or anxious about breathing 
difficulties but being able to take their own measurements reassured them that their 
measures were within normal limits.  
 
“There is no doubt that it has probably saved a couple of trips to hospital or has made me go 
to the doctor where previously I would have hung on and ended up going to hospital by 
ambulance.”  
 
Participants also described the telehealth monitoring as beneficial because it helped them to 
identify if they were getting sick earlier, which ultimately impacted on them seeking treatment 
before their condition deteriorated and required hospitalisation.   
 
“I know if my blood pressure was up the day before they will ring me...so then I’d go to the 
doctors and if there was a problem, he would find it before it blew into something huge.” 
 
Those who felt that the service had not had an impact on their hospitalisation rate generally 
described this as due to the fact that they had been living with their condition for several 
years so had already learned to recognise the early signs of an acute exacerbation. This 
group commented that they thought this type of service would be extremely beneficial for 
people who had been newly diagnosed with COPD. 
 
“I can see it being absolutely marvellous for people who are just starting to be crook because 
they don’t know what the heck is going on, they don’t know what the body can handle so it is 
all a bit scary… panic is a hard thing to control, it happens, you know it’s happening and try 
as you might you can’t stop it, and if you can’t control the panic you’ll end up in hospital 
whether you want to or not.” 
 
Participants generally agreed that receiving telehealth monitoring had provided reassurance 
and peace of mind knowing that a nurse was monitoring their results daily. Participants 
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described having more control over their condition and being more confident in self-
managing their condition as they were now more conscious of what their body was doing. 
 
Some participants also recorded their readings to take to their GP.  This prompted more 
communication with their GP and in two cases, participants used their monitoring results to 




The results of this research demonstrate that self-monitoring via home based telehealth 
equipment can, when combined with remote monitoring of patients’ results by a nurse, 
provide measureable health benefits for people living with COPD.  These benefits were 
found to include a reduction in ED presentations, hospital admissions and days in hospital.   
 
Much of the research investigating the use of telehealth technology has reported good 
outcomes in terms of reduced hospitalisations and ED presentations.17-18 However, there 
has been no consistent or definitive evidence in relation to how much this type of technology 
reduces health service utilisation9.  This research shows that although there was not a 
statistically significant difference between the groups in terms of health service utilisation, 
the intervention resulted in the telehealth group having almost half the number of COPD 
related ED presentations, hospitalisations and days spent in hospital compared to the control 
group. 
 
Prior to this study there was limited evidence as to the economic benefits of telehealth 
monitoring, particularly in relation to people with COPD1.  A recent systematic review of the 
literature available on home telemonitoring for pulmonary conditions9, found only two studies 
which conducted a detailed cost analysis of this approach and only one of these reported 
actual dollar savings.  This study by Pare1, showed a $355 saving per person in the 
intervention group over six months.  While Pare’s results are consistent with ours in so far as 
there were savings for those receiving a telehealth intervention, the $2,931 savings per 
annum found in our study were somewhat more substantial. This research therefore makes 
an important contribution to building the evidence base regarding the economic viability of 
such services within the wider health community.   
 
This research has also shown that telehealth monitoring can provide users of the service 
with more than just reduced health service contacts. Participants reported benefits relating to 
increased self-confidence, control and awareness in managing their condition, as well as an 
9 
 
improved sense of security and reduced anxiety.  Participants’ self-reports of improvement in 
self-management were supported by the increase in a sense of mastery of their disease, as 
found by the CRQ-SAS quality of life tool over time.  These results are similar to previous 
studies which also found that telemonitoring enhanced confidence in self-management,19 
improved individuals’ sense of security20 and increased their personal awareness of their 
health status.21 As with previous work exploring the acceptability of telehealth technology for 
older adults,19 participants in this study reported a high level of satisfaction with the user 
friendliness of the equipment.  
 
Daily monitoring was also found for some participants to have prompted more 
communication about their condition with their GP and in some cases the monitoring results 
were used to open discussion with their GP about reviewing their medications, 
demonstrating that participants were taking a more proactive role in managing their 
condition. 
 
If telehealth remote monitoring is to become a widely adopted and viable service for home 
care agencies in the future it is important to understand who best to target this kind of 
service to. Whilst our initial findings from participant interviews suggest that there are more 
benefits for those who have been newly diagnosed with their disease, this is something that 
needs further exploration. It is also essential that we understand how long the telehealth 
monitoring service needs to be provided to be most cost effective. What is the optimal time 
for people to learn to self-manage more effectively and be able to recognise their own 
symptoms of exacerbation without relying on the telehealth monitoring or equipment? These 
are important questions to consider in future research for telehomecare models. 
 
LIMITATIONS 
Information about participants’ pre-trial hospitalisations was not collected so the research 
was unable to explore any differences for individual health service use over time, only 
between group differences.  
 
In addition, this research relied on retrospective self-report of health system contacts. To 
assist in participant recall, calendars were given to all participants and were referred to at the 
monthly data collection phone calls. 
 
A further limitation was the timing of the study.  Due to funding constraints, the research was 
conducted over summer when participants with COPD are least likely to be hospitalised due 
to respiratory infections.22 As a consequence the hospital admission rate was markedly 
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lower than expected and the study was insufficiently powered for the difference between the 
two groups in hospital utilisation to achieve statistical significance even though the telehealth 
group’s hospital utilisation was virtually half that of the control group.  Future research needs 




This research has shown that remote monitoring of patient vital signs using telehealth 
equipment resulted in a smaller number of  health service contacts for individuals with COPD 
and resulted in significant costs savings. In terms of individual health benefits, improvements 
in participants’ self-management and control over their condition was evident and 
importantly, older people were receptive to using this type of technology and enjoyed using it 
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Table 1: Demographics 
 
  Telehealth Group (N=36) Information Only Group (N=35) P-Value 
Age Range 54 to 88 57 to 87   
Mean Age 71 74 0.201 
% Female 61.1% (N=22) 42.9% (N=15) 0.124 
% Living Alone 25.0% (N=9) 37.1% (N=13) 0.292 





Table 2: Health System Usage 
Item 
Control Group 
No of Occasions 
Mean (SD) 
Telehealth Group 
No of Occasions 
Mean (SD) 
Difference 

























Hospital LOS (days) 
162  








































































Table 3: Labour and Equipment Costs (Six months) 
 







Home Visits 8,156 136 $11,704 
Monitoring 18 




Total RN   $35,291 
 
Equipment 






All equipment $1880 $626.66 $22,560 
Monitoring system $14 per week n/a $26,208 
Total Equipment   $48,768 
Grand Total   $84,059 
 
Table 4: Net Benefits of Telehealth (6 Months) 
 






GP visits $48 +43 -$2,064 
Specialist visits $72 -1 $72 
ED visits $465 -3 $1,395 
Hospital LOS $1,468 -77 $113,036 
All   $112,439 
 





Equipment costs $48,768 
Labour costs $70,582 
Total costs $119,350 
Health system usage cost savings $224,878 
Annual cost savings $105,528 
Per person cost savings $2,931 
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